| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 26, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,271 | $2.77 | 161,016 | |
| May 26, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,271 | $0.12 | 34,354 | |
| May 26, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,727 | $2.77 | 12,800 | |
| May 26, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,727 | $0.12 | 5,060 | |
| May 26, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 8,636 | $2.77 | 23,636 | |
| May 26, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 8,636 | $0.12 | 8,636 | |
| January 14, 2011 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 6 | $1,197.80 | 6 | |
| January 14, 2011 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,499 | -- | 2,500 | |
| January 14, 2011 | CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 8 | $1,197.80 | 8 | |
| January 14, 2011 | CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,333 | -- | 3,333 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $1,197.80 | 12 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,999 | -- | 5,000 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $1,197.80 | 41 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,083 | -- | 17,083 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 83 | $1,197.80 | 83 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 34,583 | -- | 34,583 | |
| January 14, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $1,197.80 | 41 | |
| January 14, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,083 | -- | 17,083 | |
| January 14, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 8 | $1,197.80 | 8 | |
| January 14, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,333 | -- | 3,333 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,550 | $3.03 | 28,087 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 100 | $3.04 | 28,187 | |
| September 16, 2010 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.10 | 15,000 | |
| August 10, 2010 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,000 | $3.35 | 3,000 | |
| May 7, 2010 | President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $3.95 | 126,662 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
